No results found for "".

Commentary & Deal Flow

PRICED: Phoenix Pharma E500m 5NCL sr notes 4.875% at 99.459, yld 5%

HYC European Market: Deal Flow - General

PHOENIX PIB Dutch Finance BV (PHARGR) EUR500m (from EUR400-500m) Reg S sr unsec notes due 07/10/29 (5y). NCL (MWC B+40bp) (3m par call) (85% clean-up call). NR/BB+ (--/stable). Via Barc/BofA/DB (B&D)/ING/LBBW/SEB jt glocos and books. List Lux. German law. CoC. Settles 07/10. ISIN: XS2856820704. IPT: 5.375%-5.50%. Guidance: 5.125% area (+/- 0.125%). Final terms: EUR500 at 5.00% yield.

Priced: 4.875% at 99.459, yield 5.00%. +247.4bp vs DBR 0.25% 02/15/29. ms+209.4bp.

Investor calls started 07/01. Books closed at 1pm UKT 07/03. Books over EUR2bn. UOP: GCP, repayment of existing debt, including the tender offer for its EUR400m 2.375% fixed rate bearer notes due 08/05/25 (ISIN: XS2212959352), repurchase price 98.35, expires 5pm CEST 07/09/24, Barc/BofA/DB/ING/LBBW/SEB dealer managers. Biz: a leading integrated healthcare provider in Europe operating in Pharmaceutical Wholesale, Pharmaceutical Retail and Pharma Services. HQ: Marassen, The Netherlands/Mannheim, Germany.

Investor Presentation:http://www.netroadshow.com/nrs/home/#!/?show=929acbfe| Entry Code: Adelphi2024 (not case-sensitive)